Yang et al. hypothesized that this contradiction may result from the competitive binding of KLRG1 on tumor cells to the ligand E-cad, which decreases the inhibitory effect of KLRG1 on T-cells and NK cells [16]. The gene discussed is CDH1; the disease is neoplasm.